Key result
Fractional flow reserve-based percutaneous coronary intervention reduced the composite risk of all-cause death or spontaneous myocardial infarction compared to angiography-based PCI.
Why the study?
Data were limited regarding comparative prognosis and medical cost between FFR-based and angiography-based PCI among revascularized patients.
Does FFR-based PCI reduce the composite of all-cause death or spontaneous MI and lower medical costs compared to angiography-based PCI in patients with stable or unstable angina?
Cohort (n=134,613)
Yes
Does FFR-based PCI reduce the composite of all-cause death or spontaneous MI and lower medical costs compared to angiography-based PCI in patients with stable or unstable angina?
Answers are grounded in this paper and cite their sources.
In patients with stable or unstable angina, FFR-guided PCI is associated with lower risks of all-cause death and spontaneous MI, as well as lower cumulative long-term medical costs, compared to angiography-guided PCI.
There are limited data regarding comparative prognosis and medical cost between fractional flow reserve (FFR)–based and angiography-based percutaneous coronary intervention (PCI) among revascularized patients. This study evaluates prognosis and medical cost of FFR use in revascularized patients by PCI. Using the National Health Insurance Service database, stable or unstable angina patients who underwent PCI from 2011 to 2017 were evaluated. Eligible patients were divided into 2 groups according to use of FFR in PCI. Primary outcome was a composite of all-cause death or spontaneous myocardial infarction (MI). Secondary outcomes included individual components of the primary outcome, unplanned revascularization, and medical costs. Among 134,613 eligible patients, PCI was performed based on angiography (n = 129,497) and FFR (n = 5,116). During the study period, both the annual number and proportion of use of FFR in PCI increased (all P for trend <0.001). The FFR group showed significantly lower risk of the primary outcome (7.0% vs 9.5%; P < 0.001), all-cause death (5.8% vs 7.7%; P = 0.001), and spontaneous MI (1.6% vs 2.2%; P = 0.022) than the angiography group. Although the FFR group showed higher medical cost during index admission than angiography group (median: $6,265.10 vs $5,385.60; P < 0.001), cumulative medical cost after index admission was significantly lower ($2,696.50 vs. $3,142.10; P < 0.001). Use of FFR in PCI in stable or unstable angina patients showed significantly lower risk of all-cause death and spontaneous MI compared to angiography-based PCI. Although the FFR group had higher initial medical cost than the angiography group, cumulative medical cost after index admission was significantly lower.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2022) conducted a cohort in Stable ischemic heart disease or unstable angina (n=134,613). Fractional flow reserve (FFR)-based PCI vs. Angiography-based PCI was evaluated on Composite of all-cause death or spontaneous myocardial infarction (HR 0.773, 95% CI 0.685-0.872, p=<0.001). Fractional flow reserve-based percutaneous coronary intervention reduced the composite risk of all-cause death or spontaneous myocardial infarction compared to angiography-based PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: